Transcriptome Patterns of BRCA1- and BRCA2- Mutated Breast and Ovarian Cancers

نویسندگان

چکیده

Mutations in the BRCA1 and BRCA2 genes are known risk factors drivers of breast ovarian cancers. So far, few studies have been focused on understanding differences transcriptome functional landscapes associated with disease (breast vs. cancers), gene (BRCA1 BRCA2), mutation type (germline somatic). In this study, we were aimed at systemic evaluation association germline somatic mutations expression, clinical features, outcome, treatment. We performed BRCA1/2 centered RNA-seq data analysis cancers from TCGA repository using phenotype “portrayal” multi-layer self-organizing maps annotation. The results revealed considerable BRCA1- BRCA2-dependent studied Furthermore, our indicated that for both characterized by deregulation different biological functions differential associations characteristics poly(ADP-ribose) polymerase (PARP)-inhibitor signatures. Overall, study demonstrates variation transcriptomic affected as well (somatic germline). These warrant further investigations larger groups carriers refining molecular mechanisms

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Pathology of ovarian cancers in BRCA1 and BRCA2 carriers.

PURPOSE Germline mutations in the BRCA1 and BRCA2 genes confer increased susceptibility to ovarian cancer. There is evidence that tumors in carriers may exhibit a distinct distribution of pathological features, but previous studies on the pathology of such tumors have been small. Our aim was to evaluate the morphologies and immunophenotypes in a large cohort of patients with familial ovarian ca...

متن کامل

Cancers associated with BRCA1 and BRCA2 mutations other than breast and ovarian.

BACKGROUND Previous studies have reported additional cancers associated with BRCA mutations; however, the type, magnitude of risk, and sex differences remain to be clarified. The purpose of this study was to evaluate the incidence of cancers other than breast and ovarian cancer in known mutation carriers. METHODS An institutional review board-approved study identified 1072 patients who had ge...

متن کامل

Preventing breast and ovarian cancers in high-risk BRCA1 and BRCA2 mutation carriers.

OBJECTIVE To estimate the prevalence of the use of cancer risk-reducing measures among Australian BRCA1 and BRCA2 mutation carriers. DESIGN, SETTING AND PARTICIPANTS Prospective follow-up of female carriers of BRCA1 or BRCA2 mutations who had no personal history of cancer and were enrolled in a multiple-case breast cancer family cohort study (kConFab). Data, including cancer events and uptake...

متن کامل

Re: Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations.

BACKGROUND We have previously demonstrated that breast cancers associated with inherited BRCA1 and BRCA2 gene mutations differ from each other in their histopathologic appearances and that each of these types differs from breast cancers in patients unselected for family history (i.e., sporadic cancers). We have now conducted a more detailed examination of cytologic and architectural features of...

متن کامل

sequence variants of brca1 and brca2 genes in four iranian families with breast and ovarian cancer

background: brca1 and brca2 genes have been recognized to be responsible for 20-30% of hereditary breast can­cers and approximately 50% of familial breast and ovarian cancers. therefore, the demand for brca1 and brca2 muta­tion screening is rapidly increasing as their identification will affect medical management of people at increased risk. because of high costs involved in analysis of brca1 a...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: International Journal of Molecular Sciences

سال: 2021

ISSN: ['1661-6596', '1422-0067']

DOI: https://doi.org/10.3390/ijms22031266